Advanced search
Publication Cover
Clinical and Experimental Hypertension Volume 20, 1998 - Issue 5-6
Submit an article Journal homepage
46
Views
92
CrossRef citations to date
0
Altmetric
Original Article

Simultaneous Measurement of Marinobufagenin, Ouabain, and Hypertension-associated Protein In Various Disease States

H. C. Gonick Cedars-Sinai Medical Center The Burns and Allen Research Institute, 8700 Beverly Boulevard, Los Angeles, CA, 90048
,
Y. Ding Department of Medicine, University of California, Irvine, Irvine, CA, 92868
,
N. D. Vaziri Department of Medicine, University of California, Irvine, Irvine, CA, 92868
,
A. Y. Bagrov Laboratory of Cardiovascular Science, National Institute of Aging, Gerontology Research Center, Baltimore, MD, 21224
&
O. V. Fedorova Laboratory of Cardiovascular Science, National Institute of Aging, Gerontology Research Center, Baltimore, MD, 21224
Pages 617-627 | Published online: 03 Jul 2009

References

  • DeWardener H. E., Mills I. H., Clapham W. F., Hayter C. J. Studies on the Efferent Mechanism of the Sodium Diuresis Which Follows the Administration of Intravenous Saline in the Dog. Clin Sci. 1961; 21: 249–258
  • Haddy F. J., Overbeck H. W. The role of humoral agents in volume expanded hypertension. Life Sci. 1976; 19: 935–948
  • Buckalew V. M., Jr., Nelson D. B. Natriuretic and sodium transport inhibitory activity in plasma of volume expanded dogs. Kidney Int. 1974; 5: 12–22
  • Gonick H. C., Kramer H. J., Paul W., Lu E. Circulating inhibitor of sodium-potasslum-activated adenosine triphosphatase after expansion of extracellular fluid volume in rats. Clin Sci and Molec Med. 1977; 53: 329–334
  • Gruber K. A., Whitaker J. M., Buckalew V. M. Endogenous digitalis-like subutance in plasma of volume-expanded dogs. Nature 1980; 287: 743–745
  • Goto A., Yamada K., et al. Digoxin-Like Immunoreactivity: Is It Still Worth Measuring?. Life Sci. 1991; 49(21)1667–1678
  • Zhao N., Lee-Shiang L., Berova N., et al. Na,K ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: Nanogram scale CD structural analysis. Biochem. 1995; 34: 9893–9896
  • Hamlyn J. M., Manunta P. Ouabain, Digitalis-Like Factors and Hypertension. J Hypertens. Supplement Dec, 1992; 10(7)S99–111
  • Pamnani M. B., Chen S., Bryant H. J., Schooley J. F., Jr., et al. Effects of three sodium-potassium adenosine triphosphatase inhibitors. Hypertension. Sept, 1991; 19(3)316–324
  • Nardi R., Carretta R., Sawa H., et al. Characteristic variations in electrophoretic pattern of plasma proteins in essential hypertension. Lancet. 1980; ii: 182–183
  • Bagrov A. Y., Fedorova O. V., Austin-Lane J. L., Dmitrieva R. I., Anderson D. E. Endogenous Marinobufagenin-Like Immunoreactive Factor and Na+,K+-ATPase Inhibition During Voluntary Hypoventilation. Hypertension. 1995; 26(5)781–788
  • Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
  • Gonick H. C., Weiler E. W.J., Khalil-Manesh F., Weber M. A. Predominance of High Molecular Weight Na-K-ATPase Inhibitor in Essential Hypertension. Am J Hypertens. 1993; 6: 680–687
  • Hamlyn J. M., Harris D. W., Clark M. A., Rogowski A. C., et al. Isolation and Characterization of a Sodium Pump Inhibitor from Human Plasma. Hypertension. June, 1989; 13(6 Pt 2)681–689
  • Hamlyn J. M., Blaustein M. P., Bova S., DuCharme D. W., et al. Identification and Characterization of a Ouabain-Like Compound from Human Plasma. Proc Natl Acad Sci. USA Nov, 1991; 88(21)9907
  • Ludens J. H., Clark M. A., DuCharme D. W., Harris D. W., et al. Purification of an Endogenous Digitalis-Like Factor from Human Plasma for Structural Analysis. Hypertension. June, 1991; 17(6 Pt 2)923–929
  • Ludens J. H., Clark M. A., Kolbasa K. P., Hamlyn J. M. Digitalis-Like Factor and Ouabain-Like Compound in Plasma of Volume-Expanded Dogs. J Cardiovasc Pharmacol. 1993; 22(Suppl 2)S38–41
  • Rossi G., Manunta P., Hamlyn J. M., Pavan E., et al. Immunoreactive Endogenous Ouabain in Primary Aldosteronism and Essential Hypertension: Relationship with Plasma Renin, Aldosterone and Blood Pressure Levels. J Hypertension. Oct, 1995; 13(10)1131–1191
  • Krück F., Kramer H. J. Third Factor and Edema Formation. Contrib Nephrol. 1978; 13: 12–20
  • Bagrov A. Y., Dmitrieva R. I., Fedorova O. V., Kazakov G. P., et al. Endogenous Marinobufagenin-Like Immunoreactive Substance: A Possible Endogenous Na, K-ATPase inhibitor with vasoconstrictor activity. Am J Hypertension. Oct, 1996; 9(10, Pt 1)980–990
  • Bagrov A. Y., Fedorova O. V., Dmitrieva R. I., French A. W., Anderson D. E. Plasma Marinobufagenin-Like and Ouabain-Like Immunoreactivity During Saline Volume Expansion in Anesthetized Dogs. Cardiovasc Res. Feb, 1996; 31(2)296–305

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.